12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $38.0 million. As per the news, the Q1 earnings report came out 2 days ago.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
NantHealth: Q4 Earnings Insights
NantHealth (NASDAQ:NH) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
NantHealth missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.
NantHealth Reports Maryland Physicians Care Selected Co.’s Eviti Connect For Autoimmune Diseases Solution, No Terms Disclosed
NantHealth, Inc. (NASDAQ:NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Maryland Physicians Care (MPC), an existing customer of
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
NantHealth Announces Agreement With Care Continuity Inc. Aimed At ‘Enriching Data to Speed Member Care and Outcomes’
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced an agreement with Care Continuity Inc., a leader in
Return on Capital Employed Overview: NantHealth
According to Benzinga Pro data, during Q2, NantHealth (NASDAQ:NH) posted sales of $16.09 million. Earnings were up 8.35%, but NantHealth still reported an overall loss of $8.59 million.